锦天城律师事务所：IVD行业全生命周期法律监管及企业上市前合规要点解析报告（15页）.pdf

1、!#$#$/%&%&tinaliu0317 1/15 IVD!#$%&()*+!#$%&()*+,-./0./0123456123456 7878 !#$%!#$%.2&()().3*IVD+,-./0123456789+,-./0123456789.3:IVD+,;?ABCDE+,;?ABCDE.4(&)IVD+,;?87+,;?87.4(*)IVD+,;?ADE+,;?ADE.5 FF IVD+,G,HIJKLM/0N;O=PQ+,G,HIJKLM/0N;O=PQ.6(&)IVDRSTUKLRSTUKL.6 1.VWXYO=.6 2.45TU3ZO=.7 3._abc3defgO=.7(*

2、)IVDh4KLh4KL.8 1.h4iO=.8 2.jkh4O=.9 3.45lmn3opO=.9 4.h4iqO=.10(:)IVDrsKLrsKL.10 1.rsiO=.10 2.tuO=.11 3.vwxO=.12 4.yz|O=.12 5.O=.13(FF)IVDKLKL.14 1.rTU IVD O=.14 2.Y45O=.14()IVDG,HI/0NO=G,HI/0NO=.14 DE3DE3.14 !#$#$/%&%&tinaliu0317 2/15 IVD!#$%&()*+!#$%&()*+,-./0./0123456123456 99:;:;=1.“/”0“/”0,&h3,-

3、PM5G,fgO=M12-AstraZenecaBoehringer IngelheimMerckHealthcare SiemensCardinal HealthAbbottBeiGeneAbbVieAspenRocheheO=-tu AIVWXYO=-J AE/SAEADR MO$-53JHIMh()cfgrsO=M-1:e:O-MeOs-.MG,fgrsO=M-.G,/,fg!O=#e-.$%12fgM&?A()A()15216738527(*+,)A-.)A-.) 2./00 1h-Th;!#$#$/%&%&tinaliu0317 3/15 ()()*+*+,-./01 IVD(In

4、Vitro Diagnosis)0234,-5678,9):;?ABCDEFGHIJ./&K0BFL/MNOP,QRS./TU1V2022 W 1 X 30Y0Z&)_?abcdefg“hij”klZmdnopq0rstuvwxyz|IVD Sd0,-./)MN)lS./d)“”./d fgNDET(C)qV 2022 W 3 X 23 Y0l0 19 NDEG0DE2V -S IVD CmdnSw0 IVD CmxdnP0 7 IVD CmSU#0 IVD Cmmr0 IVD CmU#Uo,!0#IVD CmmP$%&()ScoU#co“*0+,-mP$4).A/0123S64s0 56U#

5、co784-Zsd9z:V ;);)IVDCm=Cm?IVD CmABCDEF?dG06WSHIc0J IVD BKL-klmMNOP0 QRS(Roche)TU(Abbott)VW(Siemens)XYZ(Beckman Coulter)?VW0sS_dnsBSab0 IVD Cmcdednfg0y:IVD mhijklm?-mn/BopSqV IVD Cm:rs0tu0vNDEwxSyz0y|./(QQR)QRDE)./(Q)NDE)./(QDE)%DE)%./(Q:DE)9./(Q:;)9DE)1D(Point-Of-Care Testing0“POCT”0Q)ODE)?Vrs./)./

6、)./MNf IVD KB(1)./)./sSmK0”K“”-m(2)./sMNKPSdKBopL-MN0WdHB0Qm)Y)jmjk401V-0N22./S3V S20 IVD Sd-0 IVD m-Tk(Independent Clinical Laboratory0“ICL”)o0KkP$?vkD 1!http:/www.camdi.org/news/10062#$%&()*#+,-.IVD/012345#6 27 78 2!https:/ 3!https:/ 8;8!#$#$/%&%&tinaliu0317 4/15 N#./-0Qk)./?mVvNDEwxSyz0ICL vSkD|D